Pfizer
Maayan Pinhassi currently serves as Senior Director of Inflammation and Immunology Commercial Development at Pfizer, a position held since February 2017, following roles as Senior Director/Team Leader and Director in Portfolio and Decision Analysis. Prior experience includes Director of Strategy and Portfolio Management at Mallinckrodt Pharmaceuticals and Senior Engagement Manager at Campbell Alliance, where Maayan specialized in corporate strategy, business development, and commercialization processes. Maayan's background also features a marketing internship at Abbott Laboratories and a marketing assistant role at Neopharm Israel, in addition to serving as a Lieutenant in the Israeli Navy, commanding patrol vessel units. Maayan holds an MBA with honors from The University of Chicago Booth School of Business and a B.Sc. in Life and Medical Sciences, graduating magna cum laude from Tel Aviv University.
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.